EUVIMEDEUVIMED entdecken
Open Access

ARL13B promotes angiogenesis and glioma growth by activating VEGFA-VEGFR2 signaling

Limin Chen, Xinsheng Xie, Tiantian Wang, Linlin Xu, Zhenyu Zhai, Haibin Wu, Libin Deng, Quqin Lu, Zhengjun Chen, Xiao Yang iD, Hua Lu, Ye-Guang Chen und 1 weitere

Neuro-Oncology · 04.05.2023 · 25 (5) · 871-885

DOI: 10.1093/neuonc/noac245 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuro-Oncology, online erschienen am 04.11.2022. Verfasst von Limin Chen und 12 weiteren Autor:innen. Beteiligte Einrichtung: Center for Experimental Medicine, The First Affiliated Hospital of Nanchang University, Nanchang, China. Hauptthemen laut MEDLINE: Endothelial Cells, Glioma. Die Arbeit wurde bisher 58-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, Natural Science Foundation of Jiangxi Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Tumor angiogenesis is essential for solid tumor progression, invasion and metastasis. The aim of this study was to identify potential signaling pathways involved in tumor angiogenesis.

Methods

Genetically engineered mouse models were used to investigate the effects of endothelial ARL13B(ADP-ribosylation factor-like GTPase 13B) over-expression and deficiency on retinal and cerebral vasculature. An intracranially transplanted glioma model and a subcutaneously implanted melanoma model were employed to examine the effects of ARL13B on tumor growth and angiogenesis. Immunohistochemistry was used to measure ARL13B in glioma tissues, and scRNA-seq was used to analyze glioma and endothelial ARL13B expression. GST-fusion protein-protein interaction and co-immunoprecipitation assays were used to determine the ARL13B-VEGFR2 interaction. Immunobloting, qPCR, dual-luciferase reporter assay and functional experiments were performed to evaluate the effects of ARL13B on VEGFR2 activation.

Results

Endothelial ARL13B regulated vascular development of both the retina and brain in mice. Also, ARL13B in endothelial cells regulated the growth of intracranially transplanted glioma cells and subcutaneously implanted melanoma cells by controlling tumor angiogenesis. Interestingly, this effect was attributed to ARL13B interaction with VEGFR2, through which ARL13B regulated the membrane and ciliary localization of VEGFR2 and consequently activated its downstream signaling in endothelial cells. Consistent with its oncogenic role, ARL13B was highly expressed in human gliomas, which was well correlated with the poor prognosis of glioma patients. Remarkably, ARL13B, transcriptionally regulated by ZEB1, enhanced the expression of VEGFA by activating Hedgehog signaling in glioma cells.

Conclusions

ARL13B promotes angiogenesis and tumor growth by activating VEGFA-VEGFR2 signaling. Thus, targeting ARL13B might serve as a potential approach for developing an anti-glioma or anti-melanoma therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Endothelial CellsGliomaHumansMiceAnimalsHedgehog ProteinsSignal TransductionNeovascularization, PathologicCell ProliferationVascular Endothelial Growth Factor Receptor-2Vascular Endothelial Growth Factor AADP-Ribosylation Factors

Stichwörter der Autor:innen

ARL13BVEGFR2intercellular communicationtumor angiogenesisvascular development

Substanzen

Hedgehog ProteinsVascular Endothelial Growth Factor Receptor-2VEGFA protein, humanVascular Endothelial Growth Factor AARL13B protein, humanADP-Ribosylation FactorsArl13b protein, mouse

Autor:innen und Institutionen

  • Center for Experimental Medicine, The First Affiliated Hospital of Nanchang University, Nanchang, China.
  • Department of Epidemiology and Biostatistics, School of Public Health, Nanchang University, Nanchang, China.
  • Center for Excellence in Molecular Cell Science, Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, Shanghai, China.
  • Genetic Laboratory of Development and Disease, Institute of Lifeomics, National Center for Protein Sciences, Beijing, China.
  • Department of Biochemistry and Molecular Biology, Tulane University School of Medicine, New Orleans, USA.
  • School of Life Sciences, Tsinghua University, Beijing, China.

ORCID-Profile: Xiao Yang

Förderung

  • National Natural Science Foundation of China
  • National Key Research and Development Program of China
  • Natural Science Foundation of Jiangxi Province

Zitieren

APA

Chen, L., Xie, X., Wang, T., Xu, L., Zhai, Z., Wu, H., Deng, L., Lu, Q., Chen, Z., Yang, X., Lu, H., Chen, Y. G., & Luo, S. (2023). ARL13B promotes angiogenesis and glioma growth by activating VEGFA-VEGFR2 signaling. Neuro-Oncology, 25(5), 871-885. https://doi.org/10.1093/neuonc/noac245

Vancouver

Chen L, Xie X, Wang T, Xu L, Zhai Z, Wu H, et al. ARL13B promotes angiogenesis and glioma growth by activating VEGFA-VEGFR2 signaling. Neuro-Oncology. 2023;25(5):871-885. doi:10.1093/neuonc/noac245

BibTeX
@article{Chen2023,
  author = {Chen, Limin and Xie, Xinsheng and Wang, Tiantian and Xu, Linlin and Zhai, Zhenyu and Wu, Haibin and Deng, Libin and Lu, Quqin and Chen, Zhengjun and Yang, Xiao and Lu, Hua and Chen, Ye-Guang and Luo, Shiwen},
  title = {ARL13B promotes angiogenesis and glioma growth by activating VEGFA-VEGFR2 signaling},
  journal = {Neuro-Oncology},
  year = {2023},
  volume = {25},
  number = {5},
  pages = {871--885},
  doi = {10.1093/neuonc/noac245}
}
Kostenlos starten →